Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Yakult, LivTech Enter into Option Agreement for Anti-Cancer Monoclonal Antibody Development Program
Yakult Honsha announced on November 8 that the company has entered into an exclusive option agreement on November 7 with the bioventure company LivTech, Inc. (based in Kawasaki, Kanagawa Prefecture) for LivTech’s LIV-2008, a humanized monoclonal anti-cancer antibody R&D program.…
To read the full story
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





